Severe X-linked Mitochondrial Encephalomyopathy Associated with a Mutation in Apoptosis-inducing Factor
Overview
Authors
Affiliations
We investigated two male infant patients who were given a diagnosis of progressive mitochondrial encephalomyopathy on the basis of clinical, biochemical, and morphological features. These patients were born from monozygotic twin sisters and unrelated fathers, suggesting an X-linked trait. Fibroblasts from both showed reduction of respiratory chain (RC) cIII and cIV, but not of cI activities. We found a disease-segregating mutation in the X-linked AIFM1 gene, encoding the Apoptosis-Inducing Factor (AIF) mitochondrion-associated 1 precursor that deletes arginine 201 (R201 del). Under normal conditions, mature AIF is a FAD-dependent NADH oxidase of unknown function and is targeted to the mitochondrial intermembrane space (this form is called AIF(mit)). Upon apoptogenic stimuli, a soluble form (AIF(sol)) is released by proteolytic cleavage and migrates to the nucleus, where it induces "parthanatos," i.e., caspase-independent fragmentation of chromosomal DNA. In vitro, the AIF(R201 del) mutation decreases stability of both AIF(mit) and AIF(sol) and increases the AIF(sol) DNA binding affinity, a prerequisite for nuclear apoptosis. In AIF(R201 del) fibroblasts, staurosporine-induced parthanatos was markedly increased, whereas re-expression of AIF(wt) induced recovery of RC activities. Numerous TUNEL-positive, caspase 3-negative nuclei were visualized in patient #1's muscle, again indicating markedly increased parthanatos in the AIF(R201 del) critical tissues. We conclude that AIF(R201 del) is an unstable mutant variant associated with increased parthanatos-linked cell death. Our data suggest a role for AIF in RC integrity and mtDNA maintenance, at least in some tissues. Interestingly, riboflavin supplementation was associated with prolonged improvement of patient #1's neurological conditions, as well as correction of RC defects in mutant fibroblasts, suggesting that stabilization of the FAD binding in AIF(mit) is beneficial.
Zhou M, Liu S, Wang Y, Zhang B, Zhu M, Wang J Nat Commun. 2025; 16(1):1804.
PMID: 39979311 PMC: 11842818. DOI: 10.1038/s41467-025-57081-5.
NADH-bound AIF activates the mitochondrial CHCHD4/MIA40 chaperone by a substrate-mimicry mechanism.
Brosey C, Shen R, Tainer J EMBO J. 2025; 44(4):1220-1248.
PMID: 39806100 PMC: 11832770. DOI: 10.1038/s44318-024-00360-6.
Jin Y, Liu X, Zhang Q, Xiong Y, Hu Y, He H Biomedicines. 2025; 12(12.
PMID: 39767564 PMC: 11673014. DOI: 10.3390/biomedicines12122657.
Novel Variant in 2 Siblings With Sensorineural Hearing Loss and Cerebellar Ataxia.
Vasquez A, Schimmenti L, Demirel N, Rabatin A, Fischer C, Pinto M Neurol Genet. 2024; 10(6):e200216.
PMID: 39601015 PMC: 11595327. DOI: 10.1212/NXG.0000000000200216.
Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population.
Feng H, Huang S, Ma Y, Yang J, Chen Y, Wang G Orphanet J Rare Dis. 2024; 19(1):342.
PMID: 39272213 PMC: 11396341. DOI: 10.1186/s13023-024-03338-z.